Latest Breaking News On - Olema pharmaceuticals - Page 5 : vimarsana.com

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, April 02, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.

United kingdomUnited statesSan franciscoGeoffrey mogilnerCompensation committee of olema board directorsOlema pharmaceuticals incCompensation committeeNasdaq listing ruleOlema pharmaceuticalsVice presidentInvestor relations

Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

Detailed price information for Lennar Corp (LEN-N) from The Globe and Mail including charting and trades.

United kingdomUnited statesEstee lauderFreeport mcmoranOlema pharmaceuticalsMccormick coMaine foods incElevance healthGoldman sachsOccidental petroleumRoivant sciences ltdPaychex incArgus researchValero energyUnitedhealth groupDow jones

Olema Oncology Reports Inducement Grants Under Nasdaq

Olema Oncology Reports Inducement Grants Under Nasdaq
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoGeoffrey mogilnerOlema pharmaceuticals incCompensation committee of olema board directorsCompensation committeeNasdaq listing ruleOlema pharmaceuticalsVice presidentInvestor relations

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonGroup plcSecurities exchange commissionPerceptive advisorsHedge funds weigh in on olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyVanguard group incOlema pharmaceuticals company profileInsider transactions at olema pharmaceuticalsBarclays plcOlema pharmaceuticals incOlema pharmaceuticals stock downOlema pharmaceuticalsGet free reportOne financialPharmaceuticals stock down

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 8%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonOlema pharmaceuticals incOlema pharmaceuticals trading downOlema pharmaceuticalsRenaissance technologiesJpmorgan chase coNews ratings for olema pharmaceuticals dailyHedge funds weigh in on olema pharmaceuticalsAcadian asset managementBlackrock incPrelude capital managementGet free reportOne financialPharmaceuticals trading downDirector cyrus harmonAsset management